|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-5-26
|
|
pubmed:abstractText |
Prognostic subgroup classification of operable breast cancers using cDNA clustering of breast cancer-related genes resembles the classification based on the combined immunohistochemical (IHC) expression of the hormone and HER-2 receptors. We here report the short-term disease-free interval (DFI) of operable breast cancers by their joint hormone receptor/HER-2 phenotype.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1573-7217
|
|
pubmed:author |
pubmed-author:AmantFrédéricF,
pubmed-author:BertelootPatrickP,
pubmed-author:BrouckaertOlivierO,
pubmed-author:CamerlynckEdwardE,
pubmed-author:ChristiaensMarie-RoseMR,
pubmed-author:DecockJulieJ,
pubmed-author:DrijkoningenMariaM,
pubmed-author:HendrickxWouterW,
pubmed-author:LeunenKarinK,
pubmed-author:NevenPatrickP,
pubmed-author:ParidaensRobertR,
pubmed-author:PintensSaskiaS,
pubmed-author:SmeetsAnA,
pubmed-author:Van BelleVanyaV,
pubmed-author:Van HuffelSabineS,
pubmed-author:Van LimbergenErikE,
pubmed-author:Van den BogaertWalterW,
pubmed-author:Vanden BemptIsabelleI,
pubmed-author:VergoteIgnaceI,
pubmed-author:WeltensCarolineC,
pubmed-author:WildiersHansH
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
115
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
349-58
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18629635-Breast Neoplasms,
pubmed-meshheading:18629635-Female,
pubmed-meshheading:18629635-Humans,
pubmed-meshheading:18629635-Immunohistochemistry,
pubmed-meshheading:18629635-In Situ Hybridization, Fluorescence,
pubmed-meshheading:18629635-Kaplan-Meier Estimate,
pubmed-meshheading:18629635-Middle Aged,
pubmed-meshheading:18629635-Phenotype,
pubmed-meshheading:18629635-Prognosis,
pubmed-meshheading:18629635-Receptor, erbB-2,
pubmed-meshheading:18629635-Receptors, Estrogen,
pubmed-meshheading:18629635-Receptors, Progesterone,
pubmed-meshheading:18629635-Treatment Outcome,
pubmed-meshheading:18629635-Tumor Markers, Biological
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors.
|
|
pubmed:affiliation |
Multidisciplinary Breast Centre, UZLeuven, Leuven 3000, Belgium.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
